Invivyd (IVVD) Current Assets (2020 - 2025)
Invivyd (IVVD) reported Current Assets of $247.5 million for Q4 2025, up 145.79% on a YoY basis from $100.7 million in Q4 2024, and up 125.44% quarter-over-quarter from $109.8 million in Q3 2025.
Invivyd (IVVD) Current Assets (2020 - 2025) Analysis & Trends
Invivyd has reported Current Assets for 6 years, with the latest figure at $247.5 million in Q4 2025.
- For the quarter ending Q4 2025, Current Assets rose 145.79% year-over-year to $247.5 million; the trailing twelve-month figure through Dec 2025 stood at $247.5 million (up 145.79% YoY), and the FY2025 full-year result was $247.5 million, up 145.79% from the prior year.
- Current Assets for Q4 2025 stood at $247.5 million, up from $109.8 million in the prior quarter.
- The five-year high for Current Assets was $680.2 million in Q3 2021, with the low at $59.3 million in Q2 2025.
- Historically, Current Assets has averaged $305.5 million across 5 years, with a median of $270.1 million in 2023.
- Annual changes were most pronounced in 2021 — Current Assets soared 425.39% — and 2025, when it plunged 65.74%.
- Invivyd's Current Assets stood at $616.7 million in 2021, then slumped by 38.88% to $376.9 million in 2022, then slumped by 40.34% to $224.9 million in 2023, then plunged by 55.23% to $100.7 million in 2024, then soared by 145.79% to $247.5 million in 2025.
- The last three Current Assets figures came in at $247.5 million (Q4 2025), $109.8 million (Q3 2025), and $59.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 247.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 247.47 Mn |
| Sep 30, 2025 | 109.77 Mn |
| Jun 30, 2025 | 59.28 Mn |
| Mar 31, 2025 | 75.83 Mn |
| Dec 31, 2024 | 100.68 Mn |
| Sep 30, 2024 | 151.10 Mn |
| Jun 30, 2024 | 173.01 Mn |
| Mar 31, 2024 | 209.88 Mn |
| Dec 31, 2023 | 224.88 Mn |
| Sep 30, 2023 | 270.10 Mn |
| Jun 30, 2023 | 309.99 Mn |
| Mar 31, 2023 | 344.62 Mn |
| Dec 31, 2022 | 376.92 Mn |
| Sep 30, 2022 | 421.60 Mn |
| Jun 30, 2022 | 481.36 Mn |
| Mar 31, 2022 | 554.30 Mn |
| Dec 31, 2021 | 616.71 Mn |
| Sep 30, 2021 | 680.16 Mn |
| Jun 30, 2021 | 396.06 Mn |
| Dec 31, 2020 | 117.38 Mn |